Cerebral hypoperfusion detected by SPECT in patients with systemic lupus erythematosus is related to clinical activity and cumulative tissue damage

Lupus

Volumn 12, Issue 11, 2003, Pages 813-819

  Lopez Longo F J ^a   Caro, N ^a   Almoguera, M I ^a   Olazaran J ^a   Alonso Farto, J C ^a   Ortega, A ^a   Monteagudo, I ^a   González, C Manuel ^a   Carreño, Luis ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

Cerebral SPECT; Neuropsychiatric lupus; SLE disease activity index (SLEDAI); SLICC ACR damage index; Systemic lupus erythematosus

Indexed keywords

CARDIOLIPIN ANTIBODY; DNA ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ADOLESCENT; ADULT; AGED; ANTIBODY BLOOD LEVEL; ARTICLE; BRAIN PERFUSION; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL FEATURE; COGNITIVE DEFECT; COMORBIDITY; CONTROLLED STUDY; CORRELATION ANALYSIS; DEPRESSION; DISEASE ASSOCIATION; DISEASE DURATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HEADACHE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; LABORATORY TEST; MAJOR CLINICAL STUDY; NEUROPSYCHIATRY; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STATISTICAL SIGNIFICANCE; SYSTEMIC LUPUS ERYTHEMATOSUS; TISSUE INJURY;

ADOLESCENT; ADULT; AGED; CEREBROVASCULAR CIRCULATION; COGNITION DISORDERS; CYSTEINE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; ORGANOTECHNETIUM COMPOUNDS; RADIOPHARMACEUTICALS; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 17744419722     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/0961203303lu470oa     Document Type: Article

References (46)

1. Ellis SG, Verity MA. Central nervous involvement in systemic lupus erythematosus: a review of neuropathologic findings in 57 cases: 1955-1977. Semin Arthritis Rheum 1979; 8: 217-221.
2. Klippel JH, Zvaifler NJ. Neuropsychiatric abnormalities in systemic lupus erythematosus: an overview. Semin Arthritis Rheum 1986; 15: 185-199.
3. Bluestein H. Neuropsychiatric manifestations of systemic lupus erythematosus. N Engl J Med 1987; 317: 309-311.
4. American College of Rheumatology ad hoc Committee on Neuropsychiatric Lupus Nomenclature. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 1999; 42: 599-608.
5. Hanly JG, Walsh NMG, Sangalang V. Brain pathology in systemic lupus erythematosus. J Rheumatol 1992; 19: 732-741.
6. Hess DC. Cerebral lupus vasculopathy. Mechanisms and clinical relevance. Ann NY Acad Sci 1997; 823: 154-168.
7. Nossent JC, Hovestadt A, Schonfeld DH, Swaak AJ. Single-photon-emission computed tomography of the brain in the evaluation of cerebral lupus. Arthritis Rheum 1991; 34: 1397-1403.
8. Rogers MP, Waterhouse E, Nagel JS et al. I-123 iofetamine SPECT scan in systemic lupus erythematosus patients with cognitive and other minor neuropsychiatric symptoms: a pilot study. Lupus 1992; 1: 215-219.
9. Szer IS, Miller JH, Rawlings D, Shaham B, Bernstein B. Cerebral perfusion abnormalities in children with central nervous system manifestations of lupus detected by single photon emission computed tomography. J Rheumatol 1993; 20: 2143-2148.
10. Emmi L, Bramati M, De Christofaro MT et al. Magnetic resonance imaging and single-photon emission computed tomography investigations of the central nervous system in systemic lupus erythematosus patients. Clin Exp Rheumatol 1993; 11: 13-20.
11. Rubbert A, Marienhagen J, Pimer K et al. Single-photon-emission computed tomography analysis of cerebral blood flow in the evaluation of central nervous system involvement in patients with systemic lupus erythematosus. Arthritis Rheum 1993; 36: 1253-1262.
12. Grunwald F, Schomburg A, Badali A, Ruhlmann J, Pavics L, Biersack HJ. 18FDG-PET and acetazolamide-enhanced 99mTc-HMPAO-SPET in systemic lupus erythematosus. Eur J Nucl Med 1995; 22: 1073-1077.
13. Kovacs JAJ, Urowitz MB, Gladman DD, Zeman R. The use of single photon emission computed tomography in neuropsychiatric systemic lupus erythematosus: a pilot study. J Rheumatol 1995; 22: 1247-1253.
14. Kodama K, Okada S, Hino T et al. Single photon emission computed tomography in systemic lupus erythematosus with psychiatric symptoms. J Neurol Neurosurg Psych 1995; 58: 307-311.
15. Colamussi P, Giganti M, Cittani M et al. Brain single-photon emission tomography with 99mTc-HMPAO in neuropsychiatric systemic lupus erythematosus: relations with EEG and MRI findings and clinical manifestations. Eur J Nucl Med 1995; 22: 17-24.
16. Lin WY, Wang SJ, Yen TC, Lan JL. Technetium-99m-HMPAO brain SPECT in systemic lupus erythematosus with central nervous system involvement. J Nucl Med 1997; 38: 1112-1115.
17. Falcini F, De Cristofaro MT, Ermini M et al. Regional cerebral blood flow in juvenile systemic lupus erythematosus: a prospective SPECT study. Single photon emission computed tomography. J Rheumatol 1998; 25: 583-588.
18. Russo R, Gilday D, Laxer RM, Eddy A, Silverman ED. Single photon emission computed tomography scanning in childhood systemic lupus erythematosus. J Rheumatol 1998; 25: 576-582.
19. Lass P, Koseda M, Lyczak E. Technetium-99m-HMPAO brain SPECT in systemic lupus erythematosus with central nervous system involvement. J Nucl Med 1998; 39: 930-931.
20. Shen YY, Kao CH, Ho YJ, Lee JK. Regional cerebral blood flow in patients with systemic lupus erythematosus. J Neuroimaging 1999; 9: 160-164.
21. Kao CH, Ho YJ, Lan JL, Changlai SP, Liao KK, Chieng PU. Discrepancy between regional cerebral blood flow and glucose metabolism of the brain in systemic lupus erythematosus patients with normal brain magnetic resonance imaging findings. Arthritis Rheum 1999; 42: 61-68.
22. Reiff A, Miller J, Shaham B, Bernstein B, Szer IS. Childhood central nervous system lupus; longitudinal assessment using single photon emission computed tomography. J Rheumatol 1997; 24: 2461-2465.
23. Awada H, Mamo HL, Luft AG, Ponsin JC, Kahn MF. Cerebral blood flow in systemic lupus erythematosus with and without central nervous system involvement. J Neurol Neurosurg Psych 1987; 50: 1597-1601.
24. Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-1277.
25. Folstein MF, Folstein SE, McHugh PR. Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-198.
26. Peña-Casanova J. Programa integrado de exploración neuropsicológica "test Barcelona ". Normalidad, semiología y patología neuropsicológicas. Editorial Masson: Barcelona, 1991.
27. Del Ser T, González-Montalvo JJ, Martinez SE, Delgado CV, Bermejo F. Estimation of the premorbid intelligence in Spanish patients with the word accentuation test and its application to the diagnosis of dementia. Brain Cognition 1997; 33: 343-356.
28. Lezak MD. Neuropsychological assessment, 3rd edition. Oxford University Press: New York, 1995.
29. Hodges JR. Cognitive assessment for clinicians. Oxford University Press: Nueva York, 1994.
30. Brown L, Sherbenou RJ, Johnsen SK. Test of nonverbal intelligence: a language-free measure of cognitive ability. Pro-Ed: Austin, 1990.
31. Golden CJ. Stroop. Test de colores y palabras. Manual. Tea: Madrid, 1994.
32. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH and the Committee on prognosis studies in SLE. The development and validation of the Systemic Lupus Erythematosus Disease Activity Index (SLEDAI). Arthritis Rheum 1992; 35: 630-640.
33. Gladman D, Ginzler E, Goldsmith C et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 1996; 39: 363-369.
34. Holman BL, Devous MD. Functional brain SPECT: the emergence of a powerful clinical method. J Nucl Med 1992; 33: 1888-1904.
35. Sabbadini MG, Manfredi AA, Bozzolo E et al. Central nervous system involvement in systemic lupus erythematosus patients without overt neuropsychiatric manifestations. Lupus 1999; 8: 11-19.
36. Gladman DD, Urowitz MB, Slonim D et al. Evaluation of predictive factors for neurocognitive dysfunction in patients with inactive systemic lupus erythematosus. J Rheumatol 2000; 27: 2367-2371.
37. Hanly JG, Fisk JD, Sherwood G, Eastwood B. Clinical course of cognitive dysfunction in systemic lupus erythematosus. J Rheumatol 1994; 21: 1825-1831.
38. Carbotte RM, Denburg SD, Denburg JA. Prevalence of cognitive impairment in systemic lupus erythematosus. J Nerv Ment Dis 1986; 174: 357-364.
39. Monastero R, Bettini P, Del Zotto E et al. Prevalence and pattern of cognitive impairment in systemic lupus erythematosus patients with and without overt neuropsychiatric manifestations. J Neurol Sci 2001; 184: 33-39.
40. Ferraccioli G, Di Poi F, Di Gregorio F, Giacomuzzi F, Guerra U. Changes in regional cerebral blood flow after a cold hand test in systemic lupus erythematosus patients with Raynaud's syndrome. Lancet 1999; 354: 2135-2136.
41. Sanna G, Piga M, Terryberry JW et al. Central nervous system involvement in systemic lupus erythematosus: cerebral imaging and serological profile in patients with and without overt neuropsychiatric manifestations. Lupus 2000; 9: 573-583.
42. Gladman DD, Urowitz MB, Ong A, Gough J, MacKinnon A. Lack of correlation among the 3 outcomes describing SLE: disease activity, damage and quality of life. Clin Exp Rheumatol 1996; 14: 305-308.
43. Ilowite NT. Premature atherosclerosis in systemic lupus erythematosus. J Rheumatol 2000; 27(Suppl 58): 15-19.
44. Urowitz MB, Gladman DD. Accelerated atheroma in lupus. Background. Lupus 2000; 9: 161-165.
45. George J, Afek A, Gilburd B, Harats D, Shoenfeld Y. Autoimmunity in atherosclerosis: lessons from experimental models. Lupus 2000; 9: 223-227.
46. Romero FI, Khamashta MA, Hughes GRV. Lipoprotein(a) oxidation and autoantibodies: a new path in atherothrombosis. Lupus 2000; 9: 206-209.